Nuvation Bio Inc. (NUVB)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-08-06) · 99.1 | ||
| 10-Q | Q1-2026 | 8-K (2026-05-04) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-03-02) · 99.1 | 8-K (2026-01-12) · 99.1 · 99.2 · 99.3 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-03) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-07) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-07) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-03-06) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-06) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-05) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-14) · 99.1 | ||
| 10-K/A | FY-2023 | |||
| 10-K | FY-2023 | 8-K (2024-02-29) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-02) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover Page | — |
|
| Document and Entity Information | — |
|
| Statements | ||
| Consolidated Balance Sheet | ||
| Consolidated Balance Sheet (P) | ||
| Consolidated Statements of Operations and Comprehensive Loss | ||
| Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (unaudited) | — |
|
| Consolidated Statements of Stockholders' Equity | ||
| Consolidated Statement of Cash Flows | ||
| Notes | ||
| 401(k) Plan | — |
|
| Accrued Expenses | — |
|
| Accumulated Other Comprehensive (loss) Income | — |
|
| Accumulated Other Comprehensive Income | — |
|
| Accumulated Other Comprehensive Income (loss) | — |
|
| Acquisition | ||
| Borrowing | ||
| Collaboration and License Agreements | ||
| Commitments and Contingencies | ||
| Cybersecurity Risk Management, Strategy, and Governance | — |
|
| Description of Organization and Business Operations | — |
|
| Fair Value Measurements and Marketable Securities Available-for-sale | ||
| Income Tax | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Leases | ||
| Merger | — |
|
| Nature of Operations | — |
|
| Net Loss Per Share | ||
| Pay Vs Performance Disclosure | ||
| Property and Equipment | — |
|
| Revenue Recognition | ||
| Significant Accounting Policies | ||
| Stock-based Compensation | ||
| Stockholders' Equity | — |
|
| Subsequent Event | ||
| Warrants | ||